Infective Endocarditis After TAVR

Region Skane4,600 enrolled

Overview

This study aims at studying the frequency of infective endocarditis after transcatheter aortic valve replacement/implantation

Since the start of transcatheter aortic valve implnatations/replacements (TAVR/TAVI) implantations in Sweden in 2008 all procedures have been added to a national database, which now contains 4500+ procedures. At the same time, all admissions to the hospital is also recorded with diagnosis in a separate database. We intend to make a nation-wide complete follow up of all TAVR/TAVI patients in swede that has received the diagnosis of infective endocarditis after the implantation. In addition data will also be collected from the national endocarditis database for detailed information of the cases.

Study Type

OBSERVATIONAL

Enrollment

4,600

Conditions

Infective Endocarditis of Aortic Valve

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: All patients that has under TAVR/TAVI in Sweden between 2008 and 2018 Exclusion Criteria: Patients unable to follow up due to emigration or missing social security number

Locations (1)

Skane University Hospital

Lund, Sweden

Outcomes

Primary Outcomes

Infective Endocarditis

Patients that have suffered an infective endocarditis will be described, where survival is one important variable

Time frame: 5 year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.